https://seekingalpha.com/article/4763298-novocures-expansion-strategy-struggles-to-translate-approvals-into-growth [Seeking Alpha]
NovoCure Limited - Ordinary Shares (NVCR)
Last novocure limited - ordinary shares earnings: 4/30 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
novocure.com/investor-relations
Company Research
Source: Seeking Alpha
Despite FDA approvals, TTFields therapy faces adoption challenges due to marginal survival benefits and high costs, impacting market growth. NovoCure's financial health shows sufficient liquidity short-term, but profit margins will compress and S&M costs will rise in 2025. I maintain a "sell" rating due to the maturing GBM market, slow adoption of new indications, and expected financial pressures. PM Images NovoCure Limited's NASDAQ: NVCR ) stock is up 42% since my “ sell ” recommendation in October, compared to S&P 500 gains of 4% during the same time. My caution with NovoCure is the lack of revenue diversification outside of This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of
Read more
Impact Snapshot
Event Time:
NVCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVCR alerts
High impacting NovoCure Limited - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
NVCR
News
- NovoCure Limited (NASDAQ: NVCR) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.MarketBeat
- Novocure to Participate in Leerink Partners 2025 Global Healthcare ConferenceBusiness Wire
- NovoCure Limited (NASDAQ: NVCR) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.MarketBeat
- NovoCure Ltd (NVCR) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Financial ... [Yahoo! Finance]Yahoo! Finance
- NovoCure (NVCR) Reports Q4 Earnings: What Key Metrics Have to Say [Yahoo! Finance]Yahoo! Finance
NVCR
Earnings
- 2/27/25 - Miss
NVCR
Sec Filings
- 3/6/25 - Form 4
- 3/6/25 - Form 4
- 3/6/25 - Form 4
- NVCR's page on the SEC website